xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacteriële middelen voor systemisch gebruik, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. aandacht moet worden gegeven aan de officiële richtlijnen betreffende het juiste gebruik van antibacteriële agentia.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastische middelen - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
clarithromycine viatris 250 mg filmomh. tabl.
viatris gx bv-srl - clarithromycine 250 mg - filmomhulde tablet - clarithromycin
clarithromycine viatris 500 mg filmomh. tabl.
viatris gx bv-srl - clarithromycine 500 mg - filmomhulde tablet - clarithromycin
clarithromycine teva 250 mg filmomh. tabl.
teva pharma belgium sa-nv - clarithromycine 250 mg - filmomhulde tablet - clarithromycin
clarithromycine teva 500 mg filmomh. tabl.
teva pharma belgium sa-nv - clarithromycine 500 mg - filmomhulde tablet - clarithromycin
voriconazol hameln 200 mg poeder voor oplossing voor infusie
voriconazol 200 mg/flacon - poeder voor oplossing voor infusie - hydroxypropylbetadex ; natriumchloride ; zoutzuur (e 507)
venoruton forte 500 mg tablet
impexeco - hydroxyethyl-o-(bèta-)-rutoside - tablet - 500 mg - hydroxyethyl-o-(bèta-)-rutoside 500 mg - troxerutin, combinations
venoruton forte 500 mg tablet
orifarm - hydroxyethyl-o-(bèta-)-rutoside - tablet - 500 mg - hydroxyethyl-o-(bèta-)-rutoside 500 mg - troxerutin, combinations
venoruton forte 500 mg (impexeco) tabl.
impexeco sa-nv - rutoside 500 mg - tablet - troxerutin, combinations